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Abstract
Background: The highly pandemic 2009 influenza A H1N1 virus infection showed distinguished skewed age
distribution with majority of infection and death in children and young adults. Although previous exposure to
related antigen has been proposed as an explanation, the mechanism of age protection is still unknown.
Methods: In this study, murine model of different ages were inoculated intranasally with H1N1 (A/Beijing/501/09)
virus and the susceptibility and pathological response to 2009 H1N1 infection were investigated.
Results: Our results showed that the younger mice had higher mortality rate when infected with the same dose
of virus and the lethal dose increased with age. Immunohistochemical staining of H1N1 antigens in mice lung
indicated infection was in the lower respiratory tract. Most bronchial and bronchiolar epithelial cells in 4-week mice
were infected while only a minor percentage of those cells in 6-month and 1-year old mice did. The young mice
developed much more severe lung lesions and had higher virus load in lung than the two older groups of mice
while older mice formed more inducible bronchus-associated lymphoid tissue in their lungs and more severe
damage in spleen.
Conclusions: These results suggest that young individuals are more sensitive to H1N1 infection and have less
protective immune responses than older adults. The age factor should be considered when studying the
pathogenesis and transmission of influenza virus and formulating strategies on vaccination and treatment.
Background
In early 2009, a novel swine-origin influenza A (H1N1)
virus emerged and then spread rapidly around the world
[1]. WHO declared a pandemic in June 2009 when con-
firmed infections were reported in total of 74 countries
and territories [2]. To date, the number of laboratory-
confirmed death from this pandemic influenza is up to
16000 cases in more than 200 countries [3]. Compared
to the 1918 strain of H1N1 virus which claimed millions
of lives, this 2009 strain is moderate and the vast major-
ity of cases were relatively mild and uncomplicated with
similar symptoms as seasonal influenza and recovered in
a few days [4]. The severity of pneumonia caused by the
2009 H1N1 influenza virus was intermediate between
that due to seasonal H1N1 virus and highly pathogenic
avian influenza H5N1 virus [5].
However, unlike seasonal influenza in which around 90%
of severe cases were the frail elderly, clinical data in the
2009 pandemic influenza showed that children and young
adults under 60 accounted for about 68.7%-90% of the
deaths (usually, in seasonal influenza, they account for
about 17%) and 71% of the cases of severe pneumonia
(usually, they account for 32%) [6,7]. The skewed age distri-
bution toward children and young adults were similar to
that in 2003 H5N1 epidemic, which had the mean age of
19.8 years [8], and similar to the 1918 H1N1 pandemic [9].
This age-related difference in infection and death rate
could not be fully explained by social activity profiles as
some household transmission studies clearly indicated that
age is a protective factor [10,11]. Previous exposure to anti-
genically related influenza viruses was proposed as a
mechanism of age protection [12,13], while lacking protec-
tive antibody and having immunocompromising underlying
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mechanisms of risk factors to infection and mortality from
the 2009 H1N1 virus, because there are a percentage of
death were apparently healthy young adults and children
[14,15]. The age factor has not been addressed in animal
models of 2009 H1N1 influenza pathogenesis and transmis-
sion. Animal age is either not specified [16] or only animals
of one age, usually young adult, such as 13 month old ferret
or 6-8 weeks mice [5,17,18], was used throughout a study.
In order to investigate the age factor for susceptibility
and pathological response to 2009 H1N1 infection inde-
pendent of preexisting cross-active antibodies in normal
healthy individuals, we infected healthy influenza-naïve
BALB/c mice of different ages with a 2009 A H1N1
influenza virus and compared their sensitivity to infec-
tion and pathology in lung and in spleen.
Methods and materials
Virus
A pandemic 2009 H1N1 virus, A/Beijing/501/09, was
isolated from a confirmed H1N1 case in China. Virus
was grown in the allantoic cavities of 10-day-old
embryonated chicken eggs. Virus-containing allantoic
fluid was harvested and stored in aliquots at -80°C until
use. This virus does not carry the D222G mutation
reported in some H1N1 pandemic strains. All infectious
experiments were performed in an approved biosafety
level 3 (BSL-3) facilities.
Mice
Female BALB/c mice were provided by Laboratory Ani-
mal Center, Military Academy of Medical Sciences, Beij-
ing, China. Mice were maintained in a specific
pathogen-free facility and were housed in cages contain-
ing sterilized feed, autoclaved bedding and drinking
water. The animal study protocol was approved by the
Institutional Animal Care and Use Committee.
LD50 of different mouse age groups
Female BALB/c mice, 4 week (young), 6 month (adult)
and 1 year (older adult) of age, were anesthetized intra-
peritoneally (i.p.) with ketamine (75 mg/kg), and inocu-
lated intranasally (i.n.) with A/Beijing/501/09 H1N1 virus
at doses of 10
3,1 0
4 and 10
5 TCID50 (n = 10 for each age-
dose group). In addition, a normal control group was set
up for each age group which was given i.n. phosphate
buffered saline (PBS). By 14 days after the infection, the
end-point for the survival experiment, the survival rate
was analyzed and lethal dose 50 (LD50) was calculated.
Viral titers in tissues
Viral titers in lung and spleen were determined by TCID50
as described [19], except that TPCK-tripsin (Sigma-
Aldrich, MO) was added into the medium (2 μg/ml) and
0.5% chicken erythrocytes were used in hemagglutination
confirming cytopathic effect (CPE) endpoint.
Immunohistochemistry
Immunohistochemical staining of H1N1 antigens in dif-
ferent group were performed using paraffin-embedded
lung and spleen tissue. Sections of 4 μm thick were cut
and mounted on charged glass slides. Sections were
heated at 60°C for 1-2 hour and dewaxed in xylene,
passed through graded alcohols, and rehydrated with
water. Immunohistochemical staining was performed at
room temperature. The reagent and wash buffer was
0.05 M Tris buffered saline plus 0.05% Tween 20
(TBST), pH7.6. Endogenous peroxidase activity was
quenched by incubation in 3% hydrogen peroxide in
TBST for ten minutes at room temperature. Slides were
then washed and incubated for twenty minutes with 5%
normal goat serum (Zhongshan Ltd, China) in TBST.
Excess blocking serum was blown off, and the slides
were incubated with polyclonal rabbit polyclonal anti-
HA antibody of H1N1 (A/California/06/09) (Cat.IA-
01SW-0100) (1:80) at 4°C overnight. Following washing,
the slides were incubated for 1 hour in HRP/Fab poly-
mer conjugated secondary antibody (Zhongshan Ltd,
China), and visualized by incubation in diaminobenzi-
dine (Zhongshan Ltd, China) for 5 minutes. The slides
were counterstained for 10 seconds using hematoxylin
(Zhongshan Ltd, China). Staining was negatively con-
trolled by substituting rabbit immunoglobulin (Ig) frac-
tion, diluted to the same Ig concentration, for the
primary antibody. Stained sections were dehydrated and
mounted.
The semiquantitative assessment of antigen expression
on the 1 day after challenge in lungs including the
bronchi and bronchioles was performed as reported [5].
Histology
For pathologic analysis, three virus infected mice from
each age group were euthanized at 1 d, 3 d and 5 d.
The lungs and spleens were collected and fixed in 10%
formalin at room temperature immediately and subse-
quently processed to paraffin embedding. Tissue sec-
tions of 4 μm from each animal were prepared and
stained with hematoxylin and eosin for examination by
light microscopy. All the samples were collected by a
standardized protocol and not biased by changes seen in
gross pathology. Parallel procedures were carried out for
uninfected control mice for each age group.
Semi-quantitative assessment of influenza virus-asso-
ciated inflammation and tissue damage in lungs and
spleen were performed. The lung damage was evaluated
as reported elsewhere [5] according to the degeneration
and necrosis of bronchi and bronchiolar epithelium, the
infiltration of inflammatory cells, alveoli degeneration
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lial hemorrhage and edema. The cumulative scores of
size and severity of degeneration or inflammation pro-
vided the total score per animal, and the average of
three mice in a group was taken as the total score for
that group.
The assessment of focal aggregation or induced
bronchus-associated lymphoid node (iBALT) was per-
formed by scoring the total number of iBALT on every
slide, and the average score of three mice in a group
was taken as the score of that group.
Semi-quantitative assessment of spleen damage was
evaluated by the decrease of lymphocytes in splenic pulp
and red pulp, the hyperemia and haemorrhage: 0 for
normal spleen tissue, 1 for mild hyperemia and haemor-
rhage, 2 for moderate haemorrhage, decreased lympho-
cytes and increased phagocytes, 3 for no obvious spleen
structure with severe decreased lymphocytes and more
increased phagocytes.
All the evaluation of tissue damage was conducted by
two independent observers. The average score of three
mice in a group was taken as the score for that group.
Statistical analysis
The significance between survival curves was analyzed
by Kaplan-Meier survival analysis with log-rank test.
O t h e rd a t aw e r ea n a l y z e du s i n gt h e2 - t a i l e dS t u d e n t ’st
test. P < 0.05 was considered significant. All analyses
were performed with Graphpad Prism software.
Results
LD50 of different ages of mice infected with a 2009 H1N1
virus
To identify the susceptibility of different age of mice to
2009 H1N1 infection, different age group of mice were
infected with different TCID50 virus. Data showed that
the survival by 14 days after challenge was 0% for all
mice in the 10
5 TCID50 groups; was 20%, 60%, 100% in
the 10
4 TCID50 groups and 60%, 100%, 100% in the 10
3
TCID50 groups for the 4-week, 6-month and 1-year old
mice, respectively. The 50% lethal dose (LD50)w a sc a l -
culated to be 10
3.3,1 0
4.2,a n d1 0
4.5 TCID50 for the 4-
week, 6-month and 1-year old female BALB/c mice,
respectively (Table 1). The results indicated that age is
protective for pandemic H1N1 infection which parallels
the human data.
Viral titers in tissues
We further investigate the virus load and pathology of
these three ages of mice infected by the A/Beijing/501/09
H1N1 virus at the dose of 10 LD50 for the respective age
(Figure 1). At 1 day after infection, the three groups of
mice had similar virus load in lung as justified by weight
(Log10TCID50/g) and the numbers were close to the
inoculation doses. At 3 days after, however, the lung viral
titer in the 4-week and 6-month old mice were close to 3
log higher than those on day 1 while the viral titer in the
1-year old mice was less than 1.5 log higher than its level
on day 1. By 5 days after infection, the lung viral titer in
the 4-week group decreased over 1 log while the level in
the two older groups remained relatively stable as com-
pared to their day 3 level. No virus load was detected in
the spleen of all age groups (Data not shown).
Immunohistochemistry for H1N1 antigen distribution
In order to identify if tissues from different ages of mice
differ in their sensitivity to H1N1 infection, we per-
formed immunohistochemical staining of mice lung and
spleen taken from animals infected with 10 LD50 dose
of 2009 H1N1 virus. Compared to the control group
with no antigen detected in lung tissue (Figure 2A-C),
in all three ages of mice, viral antigens were found in
epithelial cells of bronchioles and terminal bronchioles,
and alveolar macrophages, but not in alveolar epithelial
cells. Significantly, at 1 day after infection, most of the
epithelial cells of bronchus and bronchioles of the 4-
Table 1 Survival of mice infected with a 2009 H1N1
influenza virus
Survival at 14 days after
challenge (alive/total)
LD50
Age\challenge dose 10
3TCID50 10
4TCID50 10
5TCID50
4-week 6/10 2/10 0/10 10
3.3TCID50
6-month 10/10 6/10 0/10 10
4.2TCID50
1-year 10/10 10/10 0/10 10
4.5TCID50
1 3 5
4
6
8
10 4w  group
6m  group
1y   group
day day day
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Figure 1 Lung virus titers at 1, 3, and 5 days after H1N1 virus
inoculation. Female BALB/c mice, of 4-week, 6-month, and 1-year
old, (n = 9 for each age group) were inoculated intranasally with a
10LD50 dose (10
4.3,1 0
5.2, and 10
5.5 TCID50, respectively) dose of A/
Beijing/501/09 H1N1 virus. At indicated time, the tissues were taken
(n = 3 mice from each age group) and virus titer was determined.
***indicate P < 0.001 relative to the corresponding the different age
group mice with 4 week age group mice. Mean ± SEM.
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in the 6-month and 1-year group mice were only par-
tially stained and stained much lighter (Figure 2D-F)
despite the inoculation of a higher infection dose for the
older age groups (10
4.3,1 0
5.2,a n d1 0
5.5 TCID50 for the
4-week, 6-month and 1-year) respectively. At 3 days and
5 days after infection, lots of stained positive cells
showed necrosis and detachment (Figure 2G-L). On the
other hand, at all time points examined, there was no
positive staining in spleen in all the age groups (data
not shown). The results indicated different susceptibility
of bronchiole epithelium cells to H1N1 virus exist in
different group age mice.
Lung damage in different age groups
Compared to the control group (Figure 3A, B, C), the
pathologic examination revealed that on day 1 after infec-
tion all three groups had similar presentations with
vacuolar degeneration of bronchi and bronchiole epithe-
lium cells, little increased broad interstitial and inflam-
matory cells with age (Figure 3 D, E, F). However on day
3 and 5 after infection the 4-week group mice presented
much more severe lung damage than the two older
groups especially the lung parenchyma. On day 3, in the
4-week group, the bronchi and bronchiolar epithelium of
mice lung degenerated, showed multifocal necrosis and
collapsed into bronchi and bronchiolar lumina with
4   w e e k                6   m o n t h                   1   y e a r  
1 day 
5 day 
3 day 
L K J
I H G
F E D
C B A
control 
Figure 2 Immunohistochemical staining of H1N1 antigen in mice lung. The experiment set up is the same as in Figure 1 (inoculation at
10LD50 dose, n = 3 for each age group at each time point) except that there was a non-treated negative control group for each age. The
tissues were stained with a polyclonal anti-HA antibody. No antigen was detected in the negative control group (A-C). At 1 day after inoculation,
almost all the bronchi and bronchiolar epithelium cells in the 4-week age-group were positively stained (D), while less than half of the bronchi
and bronchiolar epithelium cells were stained brown in the 6-month and 1-year age group (E,F). At 3 days and 5 days after inoculation, most
positive stained bronchi and bronchiolar epithelium cells death and collapsed into bronchi and bronchiolar lumina (G-L). Magnification, × 200.
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Figure 3 Histopathologic development in mice inoculated with H1N1 virus. The experiment set up is the same as in Figure 2. At 1 day
after, the presentations were similar in all groups and there was little vacuolar degeneration of bronchi and bronchiole epithelium cells(D, E, F).
At 3 days and 5 days after inoculation, the damage was severe in the 4-week group (G, J) than that of 6-month (H, K) and 1-year group (I, L).
Severe interstitial edema was seen around blood vessels, apparent injured parenchyma and degenerated alveolar epithelial cells were seen with
more inflammatory cells infiltration. The histological damage (M) was semi-quantified (n = 3 mce in each group). * and ***indicate P < 0.01 and
P < 0.001 respectively relative to the corresponding the different age group mice with 4 week age group mice. Mean ± SEM. Magnification,×
200 (A-L).
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Page 5 of 11moderate numbers of lymphocytes or macrophages. The
parenchyma around bronchial had apparent lesions and
severe interstitial edema around blood vessels. Some
alveolar epithelial cells denaturated and fell into alveolar
lumina (Figure 3G). In the 6-month group, there were lit-
tle lesions of alveolar epithelial cells, peribronchial and
perivessle tissue. Some bronchus-associated lymphoid tis-
sue (iBALT) developed beside blood vessels or bronchials
(Figure 3H, Figure 4C). There was similar presentation of
lung tissue in 1 year group (Figure 3I, 4E). No iBALT
were observed in normal mice of each age group (Figure
4 B ,D ,F ) .O nd a y5a f t e rH 1 N 1i n o c u l a t i o n ,t h ed i f f e r -
ence of lung injury between the young group and the two
adult groups was more distinguished with more extended
degenerated and necrosis sites in the bronchiolar epithe-
liums, terminal bronchioles epitheliums, alveolar ducts
and alveolar sacs and less recovered bronchi and bronch-
iolar epitheliums(Figure 3J ) .B e s i d e s ,m o r ee d e m aa n d
focal hemorrhage could be detected in 4-week group
compared with 6 month and 1 year group (Figure 3K, L).
Semi-quantitative histological analysis indicated that the
lung damage in young mice was more severe than that of
adult aged mice after H1N1 inoculation (Figure 3M). In
addition, semi-quantification analysis also indicated that
iBALT formation, especially at the first three days after
infection, increased with age (Figure 4G).
Spleen damage in different age groups
To identify if different age group mice have distin-
guished immune response to H1N1 infection, the spleen
pathological change were studied. Generally, on the first
day after H1N1 challenge, the structure of spleens of
the 4-week group mice was not different from that of
control group (Figure 5A, D). However, the number of
phagocytes in red pulp and artery cuff of spleen were
relatively elevated in the 6-month and 1-year group
(Figure 5E, F).
On day 3 after H1N1 challenge, the spleens of the
4-week group presented hyperemia with no obvious
increase in phagocytes in red pulp as compared to day 1
(Figure 5G). However, in the 6-month group and 1-year
group, the number of phagocytes in red pulp increased
significantly (green arrow show), while lymphocytes in
the white pulp did not decrease, and there was more
severe hyperemia and focal haemorrhage than that on
day 1. Besides hemosiderin (red arrow show) could be
seen in white pulp and red pulp, which indicated hae-
morrhage and enhanced phagocytosis of macrophage
(Figure 5H-I).
On day 5 after H1N1 challenge, although severe hyper-
emia presented in all groups, the number of phagocytes
still did not show obvious increase in the 4-week group
(Figure 5J), but the number of phagocytes increased dra-
matically in the 6-month and 1-year group with more
hemosiderin detected (Figure 5K-L). Coincident with the
enhanced phagocytosis, the number of spleen cells in
adult mice especially in the 1-year group decreased
dramatically.
Semi-quantitative histological analysis showed that
spleen damage increased in severity with age, which per-
haps had closed relations with the excessive activation of
macrophage and then the decrease of lymphocytes in
spleen (Figure 5M).
Discussion
This study found that when challenged intranasally with
t h es a m ed o s eo f2 0 0 9H 1 N 1v i r u s ,o l d e rm i c ea r el e s s
likely to die than younger mice. This fact that age is
protective for pandemic H1N1 infection parallels the
human data. Importantly, in this mouse model of pan-
demic H1N1 infection, all mice had not been exposed
to any influenza viruses before the experiment; there-
fore, pre-existing anti-H1N1 or cross-reactive anti-influ-
enza immunity is not a mechanism to be considered for
age-related protection. On the other hand, immune
responses to pathogen infection differ by age [20-22],
and age is a factor to be considered in vaccination and
therapy strategies.
Mechanistic examination by immunohistochemistry
and pathology revealed that young mice are more sensi-
tive to 2009 influenza A H1N1 virus infection than
older mice, at least partially due to the greater sensitivity
of their bronchi epithelial cells. In the study by Munster
et al. [16] using an adult ferret model, the 2009 H1N1
virus was found to replicate efficiently in the lower
respiratory tract, and viral antigens were found in
epithelial cells of bronchioles and terminal bronchioles,
alveolar macrophages, and also type I and type II alveo-
lar epithelial cells. In contrast, seasonal influenza virus
was only found in the epithelial cells of the upper
respiratory tract, and this difference in upper versus
lower respiratory tract infection pattern was proposed as
why the novel H1N1 virus will cause a larger epidemic
than the seasonal influenza virus. This result is also in
agreement with studies by Itho et al. and Belser et al.
[18,23] that H1N1 viral antigens were detected in
bronchiolar epithelia, desquamated cells in bronchiolar
lumen, alveolar epithelium and histiocytes in thickening
alveolus interstitial. In addition, our results from the
murine model largely agree with the study in ferrets
[16,17] in that we also found most virus infection in the
lower respiratory tract and of the cell types infected,
only marked difference was that mouse alveolar epithe-
lial cells are not sensitive to H1N1 virus infection. This
difference in cell type sensitivity might be due to animal
species difference and might account for the relative
insensitivity of mice as a species to influenza infection
[24]. We suspect similar age-related sensitivity to H1N1
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Figure 4 Histopathologic examination of iBALT formation. The experiment setup was the same as Figure 2 and histopathology was
examined for day 1, 3 and 5 days after. The images of day 3 are shown (A-F) and semi-quantitation included all time points (G). (A-F) show the
iBALT formation (light microscopy). Few iBALT was observed at 4 week group (A), while for the 6 month and 1 year groups, the number of
iBALT (green arrow) especially those beside blood vessels or bronchials increased with age (C, E). No iBALT was observed in uninfected age
control groups (B, D, F). Semi-quantification of iBALT formation (Figure G) indicated that iBALT formation, especially at three days after infection,
increased with age. ***indicate P < 0.001 relative to the corresponding the different age group mice with 4 week age group mice. Mean ± SEM.
(n = 3 mce in each group). Magnification, × 100 (A-F).
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Figure 5 Histopathological examination of spleens of mice infected with 2009 H1N1 virus. The experiment set up is the same as in Figure
1. Compare to the control in different age groups (A-C), there was no significant difference at 1 day after except 1 year group with little
increased phagocytes (D-F). At day 3 after H1N1 challenge, all three age groups presented hyperemia. The number of phagocytes (green arrow)
in red pulp increased and lymphocytes in the white pulp decreased with age increased (G-I). At day 5 there was more severe hyperemia and
focal haemorrhage than that at day 3 in each group. However, at 6 month group and 1 year group, hemosiderin (red arrow) could be easily
seen in white pulp and red pulp with more severe decrease and apoptosis-like lymphocytes with age increased(J-L). (M) was the semi-
quantitative histological analysis of spleen damage. *, ** and ***indicate P < 0.05, P < 0.01 and P < 0.001 respectively relative to the
corresponding the different age group mice with 4 week age group mice. Mean ± SEM. n = 3 mice in each group. Magnification,× 400 (A-L).
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study in ferrets should offer interesting insights to the
age-distribution of the pandemic.
Related to immunohistochemical data, the virus lung
titer assay affirmed more efficient virus proliferation in
the younger mice in the first two to three days after
infection. This higher virus titer might be explained by
the more efficient infection at inoculation, as there will
be more lung cells producing viruses, and it may or may
not be due to more viruses made per mouse cell.
The iBALT, a tissue form that is not usually present
in healthy animals [25,26] has been demonstrated to
form upon certain infections and its formation is a pro-
tective immune response in that it clears influenza viral
infection with a better organized immune response than
that mediated by primary lymphoid organs which might
over-react and result in more severe lung pathology and
even death [27,28]. The role of innate response to influ-
enza infection is complicated and can both help and
inhibit viral clearance [29,30]. An effective level is neces-
sary for infection clearance [31-33] but overreaction has
been blamed to be causing deaths in young people in
the H5N1 epidemic [34,35]. It has been reported that
young mice have lower phagocytic functions and secret
less TNF-alpha than adult mice [36,37], suggesting
young mice has lower immunity than adult mice and
has less ability to organize an efficient response for
clearing influenza virus. Our data suggest that the mod-
erate inflammatory response in lung of adult and old
mice, organized with the help to iBALT, might provided
an efficient level of protective immune response to the
infection at earlier time after virus infection, while the
young mice lacked iBALT formation and had insuffi-
cient level of inflammatory response for viral clearance
and control.
H1N1 virus induces apoptosis of infected cells, which
in a degree is a resistance mechanism of the body to
viral replication [38]. In our study, at 3 days after virus
infection, shedding of injured bronchial epithelial cells
was observed, and some epithelium was seen in regen-
eration and repair stage. The regeneration of epithelium
is slightly earlier in adult mice than in young mice
(Figure 3D-F), suggesting adult mice have higher capa-
city in epithelium repair than young mice. The much
more severe pathology observed in the lung of young
mice as compared to adult and old mice appears to be
explained by young mice’s higher sensibility to infection,
higher levels of virus replication and subsequent massive
apoptosis and damage of their epithelium cells.
On the other hand, at the 10LD50 dose of H1N1 infec-
tion, we noted that the adult and older mice had much
more severe damages in their spleen than the young
mice, which might contribute to their eventual death.
This data indicate that even the end result might be the
same (although the older are more likely to survive a
lower dose that’s lethal to the young), young and older
mice die from different pathological causes. If the same
is true in humans, this serves a basis for adopting differ-
ential intervention strategies for different ages.
The murine influenza model has been widely used for
studying influenza pathogenesis, viral therapy and vac-
cines [39] and the model has been used to study this
2009 H1N1 virus. Pathological findings in mice mimic
that in the clinic [40]. In addition, mice are the animal
of choice for studying immune responses at different
ages and development stages [41-43]. The current study
found that 1) young mice are more susceptible to the
2009 pandemic influenza A H1N1 virus infection and
are more likely to die from the infection than adult and
old mice, which parallels the pandemic epidemiology in
humans; 2) this age-related sensitivity to H1N1 infection
might be explained by young mice’s higher sensitivity of
its bronchial and bronchiole epithelial cells to be
infected, a weaker innate immune response of the young
mice to control and clear infection, and therefore young
mice are more likely to die from infection-caused mas-
sive apoptosis and damage of mouse bronchial epithelial
cells and the lung structure and function. This is a first
age-comparison study in animals for 2009 H1N1 infec-
tion, and by using an influenza-naive and immunocom-
petent mouse model it studied the age factor
independently of two major influential factors of the
pandemic. The study highlights the importance of age
factor in the 2009 H1N1 virus infection and also sug-
gests that animal model data with unspecified age or
one age should be interpreted with caution. Despite the
imperfections of the animal model, these observations
might provide some mechanistic explanations for the
age distribution in the 2009 human influenza pandemic.
Conclusions
The age factor should be considered when studying the
pathogenesis and transmission of influenza virus and
formulating the vaccination and therapy strategies. The
present study explored that young individuals are more
sensitive to H1N1 infection and have less protective
immune responses than older adults.
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